Michael Golembiewski - Mar 30, 2023 Form 4 Insider Report for SEELOS THERAPEUTICS, INC. (SEEL)

Role
Chief Financial Officer
Signature
/s/ Michael Golembiewski
Stock symbol
SEEL
Transactions as of
Mar 30, 2023
Transactions value $
$0
Form type
4
Date filed
3/31/2023, 05:06 PM
Previous filing
Mar 2, 2023
Next filing
Sep 1, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SEEL Stock Option (right to buy) Award $0 +678K $0.00 678K Mar 30, 2023 Common Stock 678K $0.69 Direct F1
transaction SEEL Stock Option (right to buy) Award $0 +88K $0.00 88K Mar 30, 2023 Common Stock 88K $0.69 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option shall vest on March 30, 2024, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through such vesting date.
F2 The Reporting Person voluntarily elected to be paid 35% of his 2022 annual cash bonus in the form of an option to purchase shares of common stock of the Issuer.